These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8207344)

  • 1. In situ-forming gels for ophthalmic drug delivery.
    Kumar S; Haglund BO; Himmelstein KJ
    J Ocul Pharmacol; 1994; 10(1):47-56. PubMed ID: 8207344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels.
    Bhowmik M; Bain MK; Ghosh LK; Chattopadhyay D
    Pharm Dev Technol; 2011 Aug; 16(4):385-91. PubMed ID: 20429816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose.
    Kumar S; Himmelstein KJ
    J Pharm Sci; 1995 Mar; 84(3):344-8. PubMed ID: 7616375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model.
    Sultana Y; Aqil M; Ali A; Zafar S
    Pharm Dev Technol; 2006; 11(3):313-9. PubMed ID: 16895842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
    Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
    Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
    Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
    Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies.
    Wei G; Xu H; Ding PT; Li SM; Zheng JM
    J Control Release; 2002 Sep; 83(1):65-74. PubMed ID: 12220839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
    Cao F; Zhang X; Ping Q
    Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations.
    Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Fetoh E; Nutan MT
    Pharm Dev Technol; 2011 Oct; 16(5):497-510. PubMed ID: 20550465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PVA on the gel temperature of MC and release kinetics of KT from MC based ophthalmic formulations.
    Bain MK; Bhowmick B; Maity D; Mondal D; Mollick MM; Paul BK; Bhowmik M; Rana D; Chattopadhyay D
    Int J Biol Macromol; 2012 Apr; 50(3):565-72. PubMed ID: 22301004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbopol/pluronic phase change solutions for ophthalmic drug delivery.
    Lin HR; Sung KC
    J Control Release; 2000 Dec; 69(3):379-88. PubMed ID: 11102678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    Khan S; Warade S; Singhavi DJ
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of indomethacin Carbopol ETD 2001 gels and the influence of storage time and temperature on their stability.
    Shawesh AM; Kaukonen A; Kallioinen S; Antikainen O; Yliruusi J
    Pharmazie; 2003 Feb; 58(2):130-5. PubMed ID: 12641331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.